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Abstract: This paper makes two claims: (1) autism can be characterized as a chronic low-
grade encephalopathy, associated with excess exposure to nitric oxide, ammonia and 
glutamate in the central nervous system, which leads to hippocampal pathologies and 
resulting cognitive impairment, and (2), encephalitis is provoked by a systemic deficiency 
in sulfate, but associated seizures and fever support sulfate restoration. We argue that 
impaired synthesis of cholesterol sulfate in the skin and red blood cells, catalyzed by 
sunlight and nitric oxide synthase enzymes, creates a state of colloidal instability in the 
blood manifested as a low zeta potential and increased interfacial stress. Encephalitis, 
while life-threatening, can result in partial renewal of sulfate supply, promoting neuronal 
survival. Research is cited showing how taurine may not only help protect neurons from 
hypochlorite exposure, but also provide a source for sulfate renewal. Several 
environmental factors can synergistically promote the encephalopathy of autism, including 
the herbicide, glyphosate, aluminum, mercury, lead, nutritional deficiencies in thiamine 
and zinc, and yeast overgrowth due to excess dietary sugar. Given these facts, dietary and 
lifestyle changes, including increased sulfur ingestion, organic whole foods, increased sun 
exposure, and avoidance of toxins such as aluminum, mercury, and lead, may help to 
alleviate symptoms or, in some instances, to prevent autism altogether. 
OPEN ACCESS
Entropy 2013, 15 373 
 
 
Keywords: encephalitis; autism; nitric oxide; cholesterol sulfate; ammonia; aluminum; 
mercury; lead; glyphosate; seizures; taurine 
PACS Codes: 87.19.xm; 87.19.xt; 87.19.xw; 87.18.Vf; 87.18.Sn; 87.19.lk; 87.19.lv; 
87.19.um; 87.19.uj 
 
1. Introduction 
Autism spectrum disorders (ASD), with early childhood autism at their core, are loosely defined by 
social, cognitive, and memory deficits leading to atypical neurodevelopment [1]. It is now well 
established that such disorders, especially the more severe types at the center of the spectrum, are 
associated with gastrointestinal problems in addition to the neurological impairment [2]. A compelling 
hypothesis for the etiology of the autism spectrum, based on the concept of “entero-colonic 
encephalopathy”, is developed in [3], where parallels are drawn with hepatic encephalopathy 
associated with liver failure. In ASD and hepatic disease, a leaky gut and/or impaired liver function 
and an impaired blood brain barrier result in the penetration of both allergenic peptides and toxins 
produced by gut bacteria into the blood stream and the brain, causing neurological effects [4,5]. It is 
argued that incomplete digestion of certain opiogenic peptides such as the exorphin, β-caseomorphine, 
followed by their penetration into the brain, can modulate the GABA-ergic, serotoninergic, 
dopaminergic, and noradrenergic systems [3]. However, others have been unable to detect an excess of 
such opiates in urinary analyses of children with ASD [6], and this may suggest that some other factor 
is involved. 
Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disorder of the 
central nervous system, which can also be provoked by vaccination, and occurs most often in children, 
especially infants [7]. While it is usually associated with a viral infection, some cases are characterized 
by an autoimmune response without obvious infection, as is the case for anti-N-methyl-D-aspartate 
(NMDA) receptor encephalitis [8,9]. ADEM develops in approximately one in 1,000 measles cases, 
but can also occur less commonly following other viral infections such as varicella zoster and rubella. 
It is estimated that up to 5% of the ADEM cases are post-vaccination encephalopathies. Characteristic 
symptoms include headache, fever, seizures and coma, distinguishing the condition from multiple 
sclerosis. Spontaneous full recovery is the norm, although a recurrence can be provoked by 
vaccination. Effective treatment programs include corticosteroids and plasma exchange, suggesting 
pathologies in the blood plasma. 
It has been proposed that unhealthy diet and toxic substance exposure may be significant factors in 
the recent increased prevalence of ASD [10–13]. We have previously argued that key nutritional 
imbalances, aggravated by environmental toxins, lead to an inadequate supply of sulfate to the blood 
stream and the tissues, predisposing the susceptible child towards an increased sensitivity to 
environmental toxins [14,15]. Known offenders would include surfactants and the toxic metals 
mercury, lead, and aluminum, and suspects would include the herbicides glyphosate and atrazine. We 
have previously discussed how environmental toxins can become sources of interfacial water stress 
Entropy 2013, 15 374 
 
 
(IWS) by virtue of destructuring interfacial water, and how this can lead to the unfolded protein 
response and a destructive cascade, resulting in the extreme case in death [16]. 
Encephalitis is an inflammation of the brain, often associated with infection, which appears initially 
with symptoms such as headache, fever, confusion, drowsiness, and fatigue. It can progress to an acute 
phase with more serious symptoms such as seizures, tremors, coma, and, even death [17]. Characterized 
by edema and the release of inflammatory cytokines in the brain, encephalitis exemplifies the 
phenomenon of biosemiotic entropy as an abnormal, disrupted form of biological signaling that 
prevails in the diseased state. An ADEM-like reaction to an acute infection of the brain or a vaccine 
could lead to further neuronal damage via chronic inflammation in the brain in the ensuing months or 
years. Indeed, case reports exist of autism-like symptoms emerging in teenagers following herpes 
encephalitis [18,19]. Neonatal encephalopathy subsequent to perinatal asphyxia is a known risk factor 
for ASD, and long-term learning disabilities can develop in children who appear to fully recover [20].  
In this paper, a biosemiotic signaling cascade associated with encephalitis is discussed showing 
how depleted sulfate (SO42−) might be partially restored in the context of an overactive immune 
response to environmental triggers, brought on by severe depletion of sulfate in the blood stream. The 
original hypothesis is that the inflammation, fever, and seizures associated with encephalitis catalyze 
the synthesis of sulfate from taurine, leading to a partial renewal of sulfated proteoglycans in the brain 
and in the vasculature. Aligning in part with the hypothesis proposed in [3] that ASD is characterized 
by a chronic low-grade pathology of biosulfate depletion, loss of barrier integrity, suppressed 
autophagy, and inflammation, the signaling cascade proposed here does not depend on penetration of 
opiogenic peptides into the brain. 
We have shown previously that cholesterol sulfate deficiency seems to be a key factor in  
ASD [14,15,21]. Unlike cholesterol, cholesterol sulfate can travel freely through aqueous media, due 
to its amphiphilic nature, and it can therefore enable the export of cholesterol and sulfate from 
synthesis sites to all the tissues. This supplies a critical need, particularly for the endothelial glycocalyx 
layer (EGL), the highly-sulfated glycocalyx complex surrounding the lumen of blood vessels. The 
earlier review showed how insufficient sulfate can result in interfacial water stress (a pathological 
condition of excessive interfacial water tension that destabilizes enzymes, protein structure, and cell 
membranes) and a low zeta potential in the blood stream [16], increasing predisposition towards 
thrombohemorrhagic phenomena [THP] [22], as well as diabetes and cardiovascular disease [23]. 
The neuroinflammatory response associated with encephalopathies induces the release of free 
radicals of oxygen and nitrogen, as well as matrix metalloproteinases and cyclooxygenases, which 
attack the blood-brain barrier (BBB) and open up the tight junctions [24]. However angiogenesis 
is an important component of the recovery process, and the formation of new vessels depends 
upon the bioavailability of sulfate to populate the endothelial glycocalyx with sulfated 
proteoglycans [25]. Sulfate synthesis from the reduced-sulfur source, homocysteine [26], requires 
free-radical sources of oxygen such as superoxide to oxidize the sulfur. Taurine, an unusual sulfonated 
amino acid, is one of the most abundant free amino acids in the brain [27]. Its sulfur atom is present in 
a nearly fully oxidized state, at a +5 valence level, one short of the +6 needed for sulfate. However, the 
production of sulfate from taurine is not easily catalyzed, and the accepted dogma today is that taurine 
is metabolically inert in humans with an extremely slow turnover rate [28]. However, the paper just 
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cited reported that 25% of the traced sulfur in taurine turned up as sulfate in the urine, a transformation 
attributed to gut bacteria. 
Multiple stressors such as hypoxia [29], ammonia [30], and endotoxin [31] have been demonstrated 
to cause the opening up of tight junctions in the BBB [32], allowing not only pathogens but also small 
molecules such as glutamate, as well as neutrophils and water, to penetrate the barrier. Exposure to 
vasoactive cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-1β (INF-1β), interferon-γ 
(INF-γ), histamines, and vascular endothelial growth factor (VEGF) induces a marked increase in 
membrane permeability in the BBB [33]. Seizures are very likely to follow [34]. The ensuing 
inflammatory response achieves the goal of killing the pathogens, but there is a high risk of collateral 
damage to the neighboring neuronal tissues. 
The signaling cascade under consideration here suggests that metabolic and biophysical changes 
associated with encephalitis can activate an innate ability to produce sulfate that would ordinarily 
require sunlight exposure. This is where high fever and seizures play an important role, in providing 
the necessary energy to catalyze the production of sulfate from sulfur-containing precursor molecules 
such as homocysteine, 3-mercaptopyruvate, and, especially, taurine. We argue that this transformation 
is facilitated by endothelial nitric oxide synthase (eNOS), operating in red blood cells and platelets, as 
well as the endothelial cells lining the capillary walls, and by neuronal nitric oxide synthase (nNOS) 
operating in neurons. Taurine’s high concentration in the brain suggests that it may help in maintaining 
a reserve supply of sulfate, made available mainly during emergency conditions. 
As argued elsewhere, eNOS and nNOS are dual-purpose enzymes, with their main objective being 
the synthesis of cholesterol sulfate, and a secondary one being the synthesis of nitric oxide (nitrate) [23]. In 
the absence of L-arginine substrate, eNOS produces superoxide [35], but the purpose of this superoxide 
production had not been adequately probed. Sound theory and empirical research suggest that eNOS 
uses sunlight to catalyze production of cholesterol sulfate in the skin [21]. Several cell types that are 
known producers of cholesterol sulfate also contain eNOS, including epithelial cells, endothelial cells, 
red blood cells and platelets [23]. Therefore, it is plausible that insufficient cholesterol sulfate supply to the 
fetus in utero predisposes the child to develop ASD, a problem that is then magnified by the child’s 
later dietary deficiencies in sulfur and inadequate sun exposure to the skin. 
The section below provides evidence of impaired sulfur metabolism and excess nitric oxide 
production in ASD and shows that excess ammonia synthesis is a key sensitizing factor for 
encephalitis. Then, Section 3 shows that heparan sulfate, particularly in the lysosome, enables the 
killing and breakdown of invasive pathogens. Section 4 draws analogies between ASD and hepatic 
encephalopathy. Section 5 points out the significance of glutamate in the brain, both as a key 
neurotransmitter and as a metabolite for the renewal of ATP during impaired glucose uptake. 
Astrocytes respond to swelling by releasing taurine, glutamate, glutamine and aspartate, which can 
supply neurons with alternative fuel to protect them from mitochondrial complex I damage during an 
immune assault. Section 6 shows that the sulfonic amino acid, taurine, enables detoxifying of 
hypochlorite, a key weapon used by neutrophils in their attack on invasive pathogens. This section also 
describes how taurine chloramine, the product of the reaction of taurine with hypochlorite, can 
plausibly be metabolized to resupply sulfate. Section 7 develops the idea that seizures and high fever 
provide the necessary energy to fuel the synthesis of cholesterol sulfate by RBCs, endothelial cells, 
platelets, and neurons. Section 8 discusses environmental factors known, or plausibly believed, to be 
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synergistically involved in ammonia exposure and/or encephalopathies. Section 9 shows how 
impairments in immune response and serotonin function associated with ASD may represent a method 
for replenishing depleted cellular sulfate supplies. Section 10, then, presents the hypothesized signaling 
cascade invoked whenever the blood stream reaches dangerous instability due to depletion of sulfate 
and/or over-production of nitric oxide. Following a discussion section, we conclude with a brief 
summary of our findings. 
2. ASD, Sulfur Metabolism, Glutathione and Ammonia 
ASD, which may be viewed as a chronic, low-grade encephalitis, is linked to abnormalities in sulfur 
metabolism. Plasma levels of glutathione (GSH) are reduced in ASD [36], and an observed increased 
ratio of GSSG (glutathione disulfide, oxidized form) to GSH (reduced) implies excess oxidative stress [37]. 
ASD is also associated with a significantly reduced level of plasma sulfate and sulfur metabolites [38] 
and with the presence of abnormally high levels of Clostridia and Desulfovibrio bacteria in  
the gut [39–41]. Clostridia microbes can produce noxious phenolic compounds such as p-cresol which 
require sulfation to be detoxified, while Desulfovibrio species metabolize sulfate to hydrogen sulfide. 
Hence, both of these types of bacteria could deplete the body’s sulfate supplies [38–40]. 
Since methionine, an essential sulfur-containing amino acid, sits at the crossroads between the 
transsulfuration pathway and the methylation pathway, pulling methionine towards the transsulfuration 
pathway due to excess sulfate consumption results in insufficient methylation capacity. In utero, DNA 
methylation alters expression of multiple proteins through epigenetics [42] and as a result DNA 
hypomethylation can lead to an epigenetic reprogramming of the fetal brain to adjust to sulfur 
deficiency [13,14,43]. It has also been demonstrated that parents of children with ASD have the same 
impairment in sulfur metabolism observed in ASD [44]. The reasonable expectation is that the child 
would experience the sulfur deficiency in utero, potentially leading to reprogramming of neural 
development strategies.  
Another phenomenon seen in connection with ASD is an increase in plasma levels of nitric oxide 
(NO) [45], which can be induced by the epigenetic reprogramming to compensate for insufficient 
sulfate supplies [14]. NO has been shown to impair intestinal barrier function [46]. At the same time, 
NO plays a crucial role in defenses against an increased rate of infection through microbial penetration 
of defective barriers (both in the gut and in the skin), which are further aggravated by deficiencies in 
cholesterol sulfate bioavailability [21]. 
A significant scavenger of NO is glutathione, which forms the relatively stable nitrosylated 
molecule, S-nitrosylglutathione (GSNO) [47]. It has recently been demonstrated that the enzyme, 
glutathione-dependent formaldehyde dehydrogenase, which is widely present in both mammalian and 
bacterial cells, can metabolize GSNO, producing GSSG, ammonia and water, while oxidizing NADH 
to NAD+ [48]. Hence, a likely consequence of excess NO synthesis is the production of excess 
ammonia, with consequences in the brain, as shown in Section 4, also explaining why ASD is 
associated with overproduction of GSSG. 
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3. The Crucial Roles of Heparan Sulfate Proteoglycans 
All cells in the body are decorated around their exterior membrane with an abundant supply of 
glycosaminoglycans (GAGs), complex molecules consisting of sugars (polysaccharides) and proteins, 
which are typically highly sulfated [49]. Recently, there has been increased awareness of the 
importance to blood stability of the glycocalyx, the sulfated GAG complex decorating the luminal wall 
of blood vessels [25]. One of the key components of these GAGs is heparan sulfate (HS) proteoglycan 
(HSPG), a linear polysaccharide in which two or three HS chains are attached in close proximity to the 
surface of the cell or to its extracellular matrix proteins. It has been shown that hyperglycemia is 
associated with a decrease specifically in heparan sulfate produced by aortic endothelial cells [50], and 
an association between ASD and impaired glucose metabolism has been recognized [51]. 
A recent study of genetically engineered mice offers strong support for the hypothesis that defects 
in heparan sulfate synthesis in neurons are associated with an autistic phenotype [52]. In the 
experiment, heparan sulfate was eliminated from postnatal neurons by inactivating the gene 
encoding an essential enzyme for its synthesis. Remarkably, these mice recapitulated “almost the 
full range of autistic symptoms, including impairments in social interaction, expression of 
stereotyped, repetitive behavior, and impairments in ultrasonic vocalization” ([52], p. 5052). 
In this section, it is shown that HS in particular plays a crucial role in the lysosomes, the organelles 
residing in the cell cytoplasm which are responsible for degrading and recycling much of the debris 
that accumulates from dead cells, both native and invasive. Section 8 discusses the importance of the 
sulfated GAGs in the artery wall both for preventing blood clots and for enabling the renewal of sulfate 
supply by endothelial cells and red blood cells, energized by the excitation of neighboring water 
molecules through sunlight exposure. 
Autophagy is a catabolic process by which cells degrade damaged proteins and other metabolites 
for recycling [53,54]. Intriguingly, autophagy also plays an important role in degrading foreign 
invaders, through a process called xenophagy. In many cases, the cell uses the exact same machinery, 
involving the autophagosome and subsequently the lysosome, to degrade and recycle materials, 
whether derived as waste products of its own activities or acquired by trapping an invasive microbe. 
Xenophagy and endocytosis are both highly-stereotyped biophysical phenomena which oppose 
biosemiotic entropy. 
A clue to the role for HS in the lysosome comes from observations of the pathology that develops in 
a collection of diseases known as lysosomal storage diseases, associated with specific known genetic 
mutations often involved with impairment in sulfate metabolism [55]. A relevant example is Sanfilippo 
syndrome [56], also known as mucopolysaccharidosis (MPS) III. MPS III has four subgroups 
characterized by different enzyme impairments in the breakdown of heparan sulfate, with the most 
common and most severe form being MPS IIIA, caused by defects in the enzyme, heparan N-sulfatase. 
The results are developmental delay, slow acquisition of speech, sleep disturbances, severe hyperactivity, 
seizures, vision and hearing impairment, and early death [57]. 
In Sanfilippo syndrome, in addition to the accumulation of heparan sulfate in the lysosome, 
glycolipids such as gangliosides are also stored, even though there are no defects in the enzymes associated 
with their breakdown. Gangliosides are molecules consisting of ceramide attached to polysaccharides, 
and they are found in abundance in the nervous system. Ceramide-enriched membrane platforms 
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emerging from lipid raft domains have been shown to mediate the internalization of bacteria, viruses 
and parasites into the host cell, prior to their digestion in the phagolysosome [58]. It is plausible that 
impaired ability to break down gangliosides will lead to their accumulation in the lysosome, causing a 
bottleneck stalling further capture and digestion of invasive pathogens. Thus, the release of sulfate 
from HS may be a rate-limiting step to enable the continued breakdown of bacterial metabolites. 
The amoeba, Dictyostellum discoldeum, is an effective model of mammalian neutrophils, given its 
ability to kill and metabolize bacteria as a source of fuel [59]. Experiments with a genetically 
engineered mutant defective in the protein kil1, which is nearly homologous to a human 
sulfotransferase, have shown that kil1 is required for efficient killing of Klebsiella pneumoniae. The 
homologous human protein is involved in the addition of sulfate to sugars, as well as the synthesis of 
sulfated proteins and proteoglycans [60]. All of this suggests that sulfate plays a crucial role in the 
endocytosis and destruction of invasive bacteria. 
In an investigation of GAG degradation by reactive oxygen species (ROS) derived from 
neutrophils [61], it was suggested that the non-enzymatic decomposition route involving ROS may be 
necessary to enhance existing lysosomal carbohydrase enzyme capabilities. A plausible basis for a 
rate-enhancing effect of HS desulfation on bacterial glycolipid breakdown may be inferred from a 
report of a protective effect of a highly sulfated polysaccharide, heparin, against Fe2+-catalyzed lipid 
peroxidation in vitro [62]. In this study, fully-sulfated heparin exhibited much greater antioxidant 
activity than modified heparin from which the N- and O-sulfate groups had been removed. 
Sequestration and/or oxidation of Fe2+ by sulfated heparin, preventing Fe2+-catalyzed formation of 
ROS, were invoked to explain the observed results. It was proposed that the acidic environment 
induced by sulfate allowed iron oxidation to produce H2O rather than H2O2 as the other reaction 
product, thus safeguarding the cell from H2O2 exposure while restoring iron to its oxidized state. 
4. Insights from Hepatic Encephalopathy 
As discussed in the introduction, there may be a shared etiology between ASD and hepatic 
encephalopathy [3,63], which develops following liver failure. Both conditions involve the gut-brain 
axis. Indeed, gut-brain interactions may be central to the abnormal neural development that leads to 
behaviorial impairment in ASD [4,5]. Derangements in the γ-aminobutyric acidergic (GABA-ergic) 
and serotoninergic systems have been found in association with both ASD and hepatic encephalopathy. 
A recent review of hepatic encephalopathy revealed an important role for ammonia in inducing 
astrocyte swelling and triggering a reaction cascade [64]. Interestingly, exposure of astrocytes to 
ammonia leads to excess production of nitric oxide, which can induce further production of ammonia 
in a feedback loop involving GSNO, as previously discussed. In in vivo experiments, an ammonia 
infusion led to increased brain production of nitric oxide in rats [65]. Furthermore, the NOS inhibitor 
L-nitroarginine methyl ester (L-NAME) significantly reduced swelling in ammonia-treated cultured 
astrocytes [66], showing that nitric oxide produced by NOS was a major factor in the swelling. 
By inducing the synthesis of nitric oxide and free radicals in the brain, ammonia exposure would 
lead to the production of peroxynitrite (ONOO−), which impairs cell protein function, mainly due to 
tyrosine nitration [64]. Peroxynitrite, formed as a result of a rapid reaction between superoxide and 
nitric oxide, has a relatively long half-life, and can diffuse over several cell diameters to cause damage 
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to cell proteins [67]. Damage to the iron-sulfur clusters in mitochondrial complex I [68] can induce the 
mitochondrial permeability transition (MPT), which results in a collapse of the inner mitochondrial 
membrane potential. Such a collapse often leads to cell death by necrosis or apoptosis. In fact, 
disruption of iron-sulfur clusters by ONOO− is suspected to be the main method by which nitric oxide 
kills microbes [69]. Mitochondrial dysfunction has been identified in association with ASD [70]. 
Hyponatremia, inflammatory cytokines, and infection have all been shown to influence brain edema 
as well in association with acute liver failure. Hyponatremia has also been identified as a factor in 
ASD [71]. Furthermore, studies on immune activities in the brains of patients with ASD have shown 
increased levels of inflammatory cytokines such as TNF-α, IL-6, and IFN-γ [72]. 
5. Glutamate as a Neurotransmitter and an Energy Source 
Glutamate is one of the most abundant amino acids in the liver, kidneys, skeletal muscles and 
brain [73], and it plays many important roles in all tissues [74]. In addition to its significance as a 
neurotransmitter [75], its role in the glutamate/aspartate shuttle helps regulate cytoplasmic NADH 
oxidation to NAD+. Conversion of glutamate to α-ketoglutarate via glutamate dehydrogenase allows it 
to feed into the citric acid cycle, supplying an alternative fuel to glucose. Under conditions of excess 
exposure to hypochlorite, which impairs glucose uptake [76], glutamate could become an important 
alternative energy source to maintain neuron viability. 
Glutamate is the main excitatory neurotransmitter in the central nervous system [75]. Glutamate 
release from neuronal synaptic vesicles into the synapse triggers post-synaptic receptor response 
leading to rapid depolarization, calcium uptake, and signal transduction. The glutamate must be 
rapidly cleared from the synapse in order to reduce background noise, which would impair 
transmission effectiveness. This task is assumed mainly by astrocytes. An elegant system involves 
the conversion in astrocytes of glutamate to glutamine, consuming ammonia. Glutamine is then 
released into the extracellular fluid and taken up by neurons, which internally convert it back to 
glutamate, releasing ammonia. Because glutamine is neuroinactive, it enables safe transport of 
glutamate back to the neuron for recycling. 
Glutamate can also be metabolized by both neurons and astrocytes. Both cell types are able to 
buffer glutamate supplies, such that, under adverse conditions such as hypoglycemia or 
oxidative/nitrosative stress, glutamate can substitute for glucose as a fuel source. The importance of 
this feature is seen when glutamate enters the citric acid cycle beyond mitochondrial complex I [77], 
thus protecting complex I from oxidative/nitrosative damage. Astrocytes respond to excess serum 
ammonia by swelling, and then subsequently releasing glutamate into the extracellular fluid [78]. A 
proposal to explain this phenomenon offered in [64] suggests that astrocytes initially convert glutamate 
to glutamine in the cytoplasm, thus consuming ammonia supplied by the blood stream. However, the 
enzyme that converts glutamine back to glutamate, glutaminase, is localized to the mitochondria [64]. 
The ammonia is thus transported into the mitochondria through this process. The mitochondria can 
utilize ammonia as a buffering agent to help maintain their basic pH (typically over 8.0), while 
simultaneously removing it from the blood stream, where it can have toxic effects.  
Taurine is one of the few other biologically common molecules that have a sufficiently high pKa 
(9.0 at 25 °C as against 9.25 for ammonia) to be effective in this pH buffering role [79]. Thus, by 
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supplying ammonia to the mitochondria, the astrocyte can free up taurine and release it alongside the 
glutamate into the extracellular space, without suffering from a drop in the pH within the 
mitochondria, which would interfere with their energy production capabilities. Indeed, it has been 
demonstrated that ammonia stimulates the release of taurine from cultured astrocytes [80], as well as 
inducing excess glutamate release with associated neurotoxicity [81]. 
The astrocyte-provided glutamate thus augments the earlier supply of glutamate brought through 
the blood brain barrier, protecting neurons from energy depletion and from oxidative stress to 
mitochondrial complex I. However, the flooding of the interstitium with glutamate can lead to 
excitotoxity and subsequent neuronal damage, a problem that is implicated in neurodegenerative 
diseases like amyotrophic lateral sclerosis (ALS) [82]. Prolonged exposure to high concentrations 
of glutamate can lead to mitochondrial failure and neuronal cell death [83]. 
It has been proposed that a key component of the neuronal dysfunction in ASD involves a 
dysregulation of glutamatergic neurotransmission in the brain [84]. A similar impairment has been 
identified for the hepatic encephalopathy associated with liver failure [85]. Excess ammonia induces 
calcium uptake by neurons through stimulation of N-methyl-D-aspartate (NMDA) receptors, thus 
inducing production of nitric oxide via calmodulin signaling. It was proposed that chronic exposure to 
low doses of ammonia leads to a selective loss of NMDA binding sites for glutamate, essentially 
suppressing the neuron’s ability to respond to glutamate signaling. 
Since the glutamate-NMDA response is associated with long term potentiation [86], learning 
ability [87] and the sleep-wake cycle [88], impairment in these areas associated with both ASD and 
hepatic encephalopathy could be explained via reduced NMDA receptor sensitivity to glutamate. A 
new form of encephalitis has recently been identified which occurs primarily among young adults [8,9]. It 
is believed to be caused by antibodies against NMDA receptor proteins, which result in an inhibition of 
NMDA response. Antibody reactivity predominantly involved the hippocampus. The acute stage was 
manifested by seizures, echolalia, poor eye contact, and loss of consciousness progressing to a 
catatonic-like state. Following recovery, the patients exhibited neuronal deficits in the brain, 
manifested as poor attention and planning, impulsivity, and behavioral disinhibition. Thus, this 
condition has significant overlap with features known to be associated with ASD. In [89], it is 
proposed that childhood disintegrative disorder, early onset schizophrenia, late onset ASD, and all 
stages of anti-NMDA-receptor encephalitis may share a common etiology caused by anti-NMDA-
receptor encephalitis.  
Valproic acid is a drug used in the treatment of a wide range of disorders, including seizures, 
bipolar disorder, migraine headache, and social anxiety. It has been found that valproic acid exposure 
in the womb is a risk factor for environmentally induced ASD [90,91]. It is interesting to note that 
valproic acid also induces an excess of ammonia in the blood serum, and causes ammonia-induced 
encephalitis [92,93]. Thus, valproic acid links ammonia toxicity with ASD. Furthermore, in 
experiments with mice, valproic acid has been shown to induce overexpression of NMDA receptors 
that are involved in long-term potentiation [94]. 
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6. Taurine’s Dual Roles in Detoxification and Sulfate Renewal 
This section first discusses the role of hypochlorite produced by neutrophils as a potent antibacterial 
agent, but also as a key instigator of collateral damage to nearby neurons. It also shows that taurine 
protects neurons from damage by hypochlorite, by reacting with it to form taurine chloramine. Finally, 
it shows that taurine chloramine can potentially be further broken down to sulfoacetaldehyde, and, 
eventually, to acetyl coenzyme A and sulfate. Thus, taurine provides both protection from damage due 
to exposure to hypochlorite and a way to renew sulfate and energy supplies. 
Neutrophils readily endocytose bacteria and enclose them in a phagosome where an acidic pH 
catalyzes reactions that yield hypochlorite (HOCl) from hydrogen peroxide via the enzyme 
myeloperoxidase, effectively killing the bacteria [95]. Hypochlorite is an extremely toxic molecule, 
achieving its effects mainly by oxidizing sulfhydryl units in membrane proteins [76]. Potential 
collateral damage to neighboring cells, such as neurons and astrocytes, can damage membrane proteins, 
causing cell swelling due to excess potassium leaks. Furthermore, glucose transport, amino acid 
transport, and plasma membrane ATPases are all inhibited by HOCl, due to disruption of membrane 
transport mechanisms following the formation of disulfide bridges. In high dosages, HOCl-induced 
loss of ATP eventually results in cell lysis and death. 
Given these considerations, it is reasonable to suppose that a mechanism exists to protect 
neighboring cells from damage due to HOCl exposure. Taurine can serve effectively in such a role, by 
reacting with HOCl to produce taurine chloramine, a much less toxic molecule [96]. While it has often 
been maintained that taurine is inert, taurine chloramine is much more reactive, and therefore it is 
conceivable that it could be broken down to yield sulfate. Taurine’s sulfur molecule is unique among 
the sulfur-containing amino acids in that it is oxidized at a +5 oxidation state, just one level short of the 
+6 needed for sulfate. Thus, the conversion of taurine to taurine chloramine is a step towards the 
release of sulfate, which appears to be the ultimate goal of the entire encephalitis reaction cascade. The 
implication is that taurine buffering of the heart and brain provide a system for sulfate renewal under 
pathological conditions. 
In [97], several potential pathways were discussed, both enzymatic and non-enzymatic, which could 
contribute to sulfoacetaldehyde formation from taurine chloramine and its derivatives at sites of 
inflammation. In [98], it was demonstrated that sulfoacetaldehyde can be synthesized from taurine 
chloramine at 37 °C and pH 7.4. The synthesis rate went up by a factor of 5 at pH 5, and by a factor of 
40 when liver homogenates were added. Preliminary results indicated that brain homogenates also 
contained this unidentified enhancing factor. The authors proposed the likely existence of a complete 
route for taurine catabolism, which would however only be available under the conditions of oxidative 
stress associated with microbial infection. 
It has been shown that the anaerobic bacterium, Alcaligenes defragrans NKNTU, can oxidize 
taurine to sulfoacetaldehyde and then to sulfite (SO32−) and acetyl coenzyme A [99]. Such a reaction 
would fit the expectations for the signaling cascade under consideration, because sulfite readily 
oxidizes to sulfate, and acetyl coenzyme A is the substrate for the citric acid cycle to generate ATP. 
Thus, taurine could offer cells an alternative fuel other than glucose, something that would be valuable 
under conditions of exposure to hypochlorite, which impairs glucose uptake. Whether humans can 
utilize a similar pathway remains to be demonstrated. 
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The enzyme, sulfoacetaldehyde acetyltransferase, requires magnesium as a cofactor, and 
magnesium deficiency has been implicated in ASD [100,101]. Magnesium deficiency has also 
been shown to be a factor in attention deficit hyperactivity disorder (ADHD), and use of 
magnesium supplements along with vitamin B6 resulted in improvements in ADHD symptoms [102]. 
Indeed, magnesium sulfate readily crosses the blood-brain barrier and raises the threshold for 
seizures in rats [103] and in humans [104]. Perhaps both the magnesium and the sulfate are 
significant factors in observed improvements, as placebo-controlled studies failed to show a benefit 
with magnesium oxide supplements for ASD [105]. 
Further evidence of a role for magnesium comes from research on non-human models. In 
experiments on the amoeba, D. discoldeum, a mutant with a defective form of the protein kil2 
exhibited an impaired ability to break down proteins in the cell walls of certain bacteria following 
phagocytosis [106]. The experiments demonstrated conclusively that kil2 enables magnesium to be 
pumped into the lysosome, and that this magnesium enrichment is essential for the proper function of a 
protease that breaks down the bacterial cell walls. Thus, there appears to be a direct link between 
magnesium deficiency and defective clearance of bacteria. In another experiment, dietary 
magnesium deficiency in rats induced enhanced NO production, resulting in a depletion of 
glutathione in red blood cells [107]. Neutrophils from the deficient rats exhibited 3–5 fold 
increases in superoxide generation. 
7. Seizures, Electromagnetic Fields, and Sulfate Synthesis by RBCs 
It has always been recognized that water is essential to life. The human body is made up of 90% 
water by molecule count. Water has many unique physical properties that have made it the subject of 
intense studies, but most biochemists are unaware of the remarkable discoveries that are being made in 
the field of physical chemistry, and, especially, of how these unique properties of water might impact 
biological systems. Particularly relevant to our discussion here is the seminal work by Gerald Pollack 
and his colleagues [108,109], who have demonstrated that water near hydrophilic charged surfaces 
behaves very differently from the bulk water. It is easy to see the connection with the glycocalyx [25], 
the polyanionic field of sulfated GAGs attached to the endothelial membranes of the arteries and the 
microvasculature. The sulfate headgroups provide hydrophilicity, negative charge density, and high 
polarizability. Through experimental studies with tubes and dyes, Pollack’s team has been able to 
show that a layer of substantially more viscous and impenetrable water accumulates near charged 
hydrophilic interfacial surfaces, water that is in a semi-crystalline state and resistant to flow. He has 
coined the term “exclusion zone” to characterize this special layer. Furthermore, exposure to light 
stimuli, particularly infrared light, causes this exclusion zone to grow dramatically, up to four times its 
original size [110]. 
A recent review paper on the topic of water’s special properties can help the non-specialist grasp the 
relevant concepts [111]. Central to this discussion are “coherence domains,” [CDs] which are likely to 
comprise Pollack’s exclusion zones [EZs], large regions of semi-crystalline water almost completely 
without solutes. Remarkably, the interfacial water adjacent to polyanionic biomembranes excludes red 
blood cells, bacteria, colloidal gold and molecules like serum albumin [112]. The water molecules in 
these special EZs/CDs can enter an excited state upon exposure to electromagnetic radiation such as 
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light stimuli, providing the energy to fuel redox reactions which form the basis of metabolism in 
biology. The electron conductivity of the water layer next to a negatively charged hydrophilic surface, 
such as that provided by the sulfate moiety, is increased by up to five orders of magnitude compared to 
the bulk water [113]. Hydrogen ions are easily transported through highly structured water by the 
Grotthuss mechanism [114], in which hydrogen bonds and covalent bonds are sequentially broken and 
reformed [115], greatly enhancing the reactivity of acid-base reactions. 
Elsewhere [16,21,23], evidence has been presented showing that eNOS in cells near the surface of 
the skin plausibly utilizes superoxide to synthesize sulfate in response to sunlight. It is well established 
that eNOS synthesizes both superoxide and nitric oxide [34]. Indeed, synthesis of superoxide requires 
significantly fewer constraints, and we believe that this is eNOS’ main function. Nitric oxide is only 
synthesized after a complex cascade involving calcium influx, calmodulin binding, detachment from 
the membrane, and VEGF-stimulated phosphorylation, as well as a dependence on the bioavailability 
of L-arginine as substrate and tetrahydrobiopterin as cofactor.  
Red blood cells contain abundant eNOS, but they maintain very low bioavailability of  
L-arginine [116], suggesting that their eNOS serves some other purpose besides nitric oxide 
synthesis. The eNOS dimer forms a central cavity containing a zinc ion, bound to four sulfurs from 
four highly-conserved cysteine residues in the eNOS molecule [117]. The positive charge of the 
zinc ion could draw superoxide into the cavity, allowing sulfate to form when the surrounding 
water is energized by sunlight. Given that Zinc is deficient in ASD [118], its absence would impair 
the function of eNOS in producing cholesterol sulfate. From the finding that persulfides serve as 
substrates for bacterial sulfur-oxidizing enzymes [119], it is reasonable to hypothesize that 
glutathione persulfide (GSSH) and/or several other sulfur species may act as the proximal sulfur 
donor for eNOS-catalyzed sulfate synthesis. Details of the proposed basis for eNOS-facilitated 
sulfate production are found in [23]. 
eNOS binds to caveolin, the protein that is necessary for the formation of caveolae, which are 
small dimples or invaginations in the membrane surface. In fact, when attached to the membrane at 
caveolae, eNOS binds to a complex of caveolin with gluthathione-S-transferase [120]. Caveolin also 
binds cholesterol and plays an essential role in trafficking cholesterol from the endoplasmic 
reticulum through the Golgi complex to the plasma membrane [121]. eNOS bound to caveolin is 
disabled from producing nitric oxide. Yet, binding to caveolin would enable eNOS to provide sulfate 
for cholesterol sulfate production in the caveolae. It has been demonstrated that red blood cells are able to 
store electromagnetic energy through conversion of their shape from stomatocytic to echinocytic [122], and 
this shape change may be important for activating eNOS in the membrane at caveolae. 
It is conceivable, although speculative, that the fever and seizures associated with encephalitis 
provide energy to allow the metabolism of taurine to sulfate. It has been observed anecdotally that 
fever often induces dramatic improvements in social interactions and speech in ASD children [123]. 
Experiments on rabbits have demonstrated that pyrogen IL-1, a known fever-inducing cytokine, 
induces increased levels of taurine in the cerebral spinal fluid (CSF), along with increased levels of 
GABA (γ-aminobutyric acid), an inhibitory neurotransmitter [124]. Applying heat shock alone induced 
the taurine increase but not the GABA increase. In [123], it was proposed that those children with ASD 
who failed to respond positively to fever may have had severe deficiencies in taurine. It seems possible 
that the extra energy supply provided by fever and seizures is sufficient, along with HOCl and other 
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ROS released in response to cytokines, to oxidize the sulfur in taurine (from +5 to +6, sulfate), and 
therefore to renew sulfate supply. 
A group of Japanese researchers have discovered a remarkable ability of human neutrophils to 
respond to a 6Hz magnetic field in the presence of visible light and at an optimal temperature of 
40 °C (104 °F) [125]. Six Hz is the characteristic frequency of therapy-resistant limbic seizures [126], 
and the optimal temperature matches a high fever. The neutrophils respond by enhancing calcium 
uptake and initiating microbe phagocytosis, a response that is also characteristic of neutrophils in the 
presence of external ATP. A similar phenomenon can induce firefly luminescence [127]. Plausibly, 
fever combined with seizures could.induce usable energy. 
If these ideas are valid, then the high fever and seizures associated with encephalitis may be vital 
for the regeneration of sulfate supplies. The fever produces an effect similar to that of the heat 
produced by infrared light, and seizures may induce an electromagnetic field to energize the water, for 
example inside the eNOS cavity, replacing the role of UV light. Such changes would support synthesis 
of sulfate, by both eNOS in endothelial cells, red blood cells, and platelets suspended in the blood 
stream, in addition to sulfate coming from the breakdown of taurine described in Section 6 above. 
It is likely that nNOS (neuronal nitric oxide synthase) in neurons also produces cholesterol sulfate 
in response to seizures. In vitro experiments have demonstrated that nitric oxide produced by nNOS 
initiates seizure-like events in the hippocampus and entorhinal cortex [128]. Furthermore, an 
increase in superoxide synthesis follows immediately in response to the seizure. This implies that the 
seizure induces superoxide production, which supports the reasonable supposition that sulfate 
synthesis requires superoxide [23]. 
Low zinc levels in the hippocampus are associated with increased risk of epilepsy in mice [129], 
suggesting a role for zinc in the nNOS cavity. Zinc deficiency also exacerbates loss in blood-brain-
barrier integrity [130], which may result from impaired cholesterol sulfate supply. Zinc deficiency 
also leads to an increased risk of infection [131], likely due to impaired barrier function in the gut 
and skin following sulfate depletion [132]. 
8. Environmental Factors 
There are several environmental factors that could work synergistically to induce a low-grade 
encephalitic state, often involving ammonia synthesis and/or sulfate depletion. Glyphosate, the active 
ingredient in Roundup, is a likely primary factor in gut dysbiosis. This would work synergistically 
with dietary factors such as thiamine deficiency and excess sugar and processed carbohydrates, leading 
to yeast overgrowth and blood sugar instabilities, as well as exposure to toxic metals such as lead 
(through ingestion of lead paint) and aluminum (through vaccination and aluminum-containing 
sunscreens and antiperspirants). Such environmental toxins along with mercury from various sources 
can impact the mother during pregnancy to induce sulfate deficiencies in the developing fetus. 
Continued nutritional inadequacies and exposure to environmental toxins postnatally will have 
synergistic effects. In this section a few factors are singled out. The ones discussed, however, are 
meant to be representative rather than exhaustive. 
Glyphosate: In [133], it was proposed that impaired metabolism of aromatic amino acids might play 
a role in ASD. Glyphosate, the active ingredient in the popular herbicide, Roundup is known to disrupt 
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aromatic amino acid metabolism in plants [134]. Glyphosate exposure to gut bacteria could elicit a 
similar response, deflecting aromatic amino acids towards toxic phenolic compounds such as  
p-cresol [135]. It has recently been shown that glyphosate exposure shifts the distribution of gut 
bacteria from beneficial towards pathogenic forms [136]. In [133], it was proposed that excess 
synthesis of p-cresol from the aromatic amino acid precursor, phenylalanine, by the pathogenic gut 
bacterium Clostridium difficile might explain impaired sulfation capacity in association with ASD. 
Sulfation of p-cresol to detoxify it would result in a depletion of available sulfation capacity.  
C. difficile is the most frequent form of colitis in hospitals, and it is a growing problem today, resulting 
in severe diarrhea following antibiotic treatments. C difficile toxins are known to destroy epithelial 
cells, opening up the tight junctions [137]. In [138], it was reported that individuals with high urinary 
levels of p-cresol sulfate had low urinary ratios of acetaminophen sulfate to acetaminophen 
glucuronide following acetaminophen administration, directly illustrating impaired sulfation capacity 
and therefore an impaired ability to detoxify acetaminophen.  
Glyphosate could also play a role in ammonia synthesis by gut bacteria, as it has been shown to 
enhance the activity of phenylalanine ammonia lyase (PAL), an enzyme found in plants, microbes, and 
mammals that converts phenylalanine to trans-cinnamate, releasing ammonia [139,140]. This would 
provide an important source of ammonia to compromise blood brain barrier, initiating the signaling 
cascade presented in this paper.  
Thiamin Deficiency: Wernicke’s encephalopathy, a condition characterized by ataxia, confusion, 
and impaired short-term memory, is usually caused by excess alcohol consumption [141], but infantile 
cases can arise due to excess carbohydrate consumption in conjunction with thiamine deficiency, and 
this can induce epilepsy [142]. A case study of a 3-year-old boy with infantile autism and a severe 
eating disorder resulted in seizures and loss of consciousness, which was effectively treated with high-
dose thiamine administration [143]. Even in the presence of adequate thiamine ingestion, impaired 
thiamine absorption leading to Wernicke’s encephalopathy can occur in association with ulcerative 
colitis [144]. There may be a connection with glyphosate here as well, since a species of Pseudomonas, 
a common gut pathogen, fully degrades glyphosate, but absolutely depends upon thiamine [145]. 
Thiamine uptake by these bacteria could deplete its supply to the body. These studies, collectively, 
suggest a link between ASD, inflammatory gut, and encephalopathies. 
Sunscreen and Aluminum: Because sunlight catalyzes eNOS’ synthesis of sulfate [23], it is 
expected that insufficient sunlight penetration due to excess use of sunscreen would interfere. 
Furthermore, many high-SPF sunscreens contain aluminum hydroxide as an emulsifier, and aluminum 
binds with calmodulin with an affinity that is ten-fold that of calcium [146]. This would force eNOS to 
switch from sulfate synthesis to NO synthesis in the epidermis, the endothelium and in RBCs. Since 
impaired cholesterol sulfate synthesis leads to increased skin permeability, aluminum is likely to 
penetrate into cells in the skin and in the blood stream, resulting in a positive-feedback effect.  
Aluminum is also added to several vaccines as an adjuvant. Epidemiological studies comparing 
ASD rates for several countries have revealed a strong correlation between the cumulative aluminum 
exposure from mandatory vaccines and the incidence of ASD [147]. Children with ASD, due to their 
impaired serum sulfate levels, would be impaired in the ability to dispose of aluminum. In a recent 
paper, Blaylock has proposed that aluminum’s toxicity to neurons results from a combination of the 
induction of inflammatory cytokines and chemokines and the induction of excitotoxic glutamate [148]. 
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Both in vitro and in vivo evidence demonstrate that aluminum increases both glutamate levels and  
pro-inflammatory cytokines like TNF-alpha in the brain [149–154], thus promoting an encephalitic 
reaction cascade. Aluminum has been shown to facilitate increases in intracellular calcium and ROS 
that are induced by other neurotoxicants, such as glutamate and ferrous iron [155]. It likely achieves 
this effect by enhancing the effect of ferrous-iron-induced peroxidation of fatty acids in the plasma 
membrane [156]. Our own studies have shown a strong association between aluminum-containing 
vaccines and seizures as an adverse reaction [157]. Hence, aluminum, if not the primary cause, must 
nevertheless promote the encephalitic state associated with ASD. 
Mercury and Lead: Both mercury and lead have toxic effects, and they can work synergistically to 
enhance toxicity [158]. Elevated mercury body-burden in subjects diagnosed with ASD was associated 
with transsulfuration abnormalities, likely arising from increased oxidative stress and decreased 
detoxification capacity [36]. Mercury in the yearly influenza vaccine adds to the mercury burden in 
other required childhood vaccines, such as Hepatitis-B. Acute cases of childhood lead poisoning can 
lead to an encephalopathy characterized by pallor, vomiting, and loss of consciousness [159]. Milder 
forms of lead poisoning are known to lead to learning disabilities, but whether, in the extreme, lead 
poisoning might induce ASD is not clear. Children with acute lead poisoning can develop mental 
deficits, seizures, optic atrophy, and sensory-motor deficits long after the acute poisoning experience 
has passed [160]. In an experiment exposing rats to lead intraperitoneally, it was determined that 
hippocampal cells were susceptible to excess apoptosis, after the rats were treated for just 7 days with 
15 mg/kg of lead acetate [161]. This experiment confirms that, at least in rats, lead can penetrate the 
BBB and damage the hippocampus. 
Dietary Carbohydrates and Phytates: Excess dietary processed high-glycemic index carbohydrates 
can lead to erratic insulin control, with hyperglycemia postprandially followed by hypoglycemia a few 
hours later due to over-stimulation of insulin production [162]. Insulin-induced hypoglycemia can 
itself disrupt the BBB [163]. In these experiments, intraperitoneal injection of magnesium sulfate 
protected rats from insulin-induced BBB dysfunction. We hypothesize that sulfate may have played a 
greater role than magnesium in ameliorating the effects of insulin on the BBB, directly through 
replenishment of sulfate in the barrier. If eNOS requires its zinc cofactor to catalyze sulfate synthesis, 
then zinc deficiency could lead to sulfate deficiency. Excess dietary phytates from nuts, seeds and 
grains can result in zinc deficiency due to tight binding of phytates to zinc, particularly in the context 
of impaired zinc intake in reduced animal-based food sources [164]. Glyphosate may play a role here 
by shifting the balance in gut biota away from the beneficial lactobacilli, which produce the enzyme 
phytase that can break down phytates and improve mineral absorption [165]. Furthermore, both 
glyphosate and glyphosate-resistance gene modification have been shown to reduce the levels of zinc 
and sulfur in soy [166].  
Sugar and Yeast Overgrowth: It has been recently demonstrated that different forms of 
enterobacteria have varying degrees of efficiency in processing different sugars. In particular,  
short-chain fructoligosaccharides, found, for example, in wheat, favor growth of more pathogenic 
forms of E. coli [167]. Furthermore, these pathogenic forms encourage growth of yeast, which can 
produce excess ammonia under stressful conditions [168], thus inducing the blood-brain barrier 
dysfunction leading to chronic inflammation and ASD. In fact, many varieties of yeast have a 
functional PAL enzyme, which could be influenced by glyphosate to over-produce ammonia [169].  
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A pathology linking yeast ammonia production and ASD has been recently proposed [170]. A study of 
peripheral blood mononuclear cells taken from children with ASD showed elevated TNF-α production 
in the gastrointestinal tract, indicative of inflammation, and nearly 1/3 of the children had overgrowth 
of Candida albicans in their colon [171]. 
9. Anergy and Serotonin Impairment 
Another alternative approach to renewing sulfate that may exist in ASD is through exploitation 
of invasive bacteria that are not efficiently killed due to the impaired immune response found in 
association with ASD [172,173]. Thus, anergy allows the host to potentially take advantage of the 
bacteria’s innate ability to synthesize sulfate or sulfate-containing polysaccharides, which, in turn, 
are essential for restoring immune function. Utilizing nutrients provided by live bacteria is not without 
precedent: gut bacteria provide important nutrients to the body, such as cobalamin and vitamin K 
(menaquinone), and they metabolize fructose and indigestible fiber into short-chain fatty acids that are 
then absorbed through the intestinal wall [174]. 
A statistically significant increased presence of multiple infective agents in the blood has been 
identified in subjects diagnosed with ASD, compared to normal controls, including Chlamydia 
pneumoniae, Mycoplasma ssp., and Human Herpes Virus-6 [175]. Chlamydia is especially significant 
for our arguments, as it has been demonstrated in in vitro studies that Chlamydia is capable of 
producing a type of polysaccharide that is almost indistinguishable from heparan sulfate [176]. High 
concentrations of this polysaccharide were detected specifically in intracellular vacuoles harboring 
Chlamydia, in three strains of eukaryotic cells that were impaired in different ways in their ability to 
produce heparan sulfate. This result supports the hypothesis that Chlamydia can provide heparan 
sulfate, and this may ironically be beneficial to the host. The product produced by the bacterium 
includes glucosamine as well as sulfate, and these are the two key components of the extracellular 
matrix that have been shown to be reduced in the context of hyperglycemia [62]. A similar role for 
Chlamydia in producing heparan sulfate may allow it to serendipitously restore the endothelial 
glycocalyx in cardiovascular disease [23]. Chlamydia is not unique in this ability to synthesize heparan 
sulfate, as this capability has also been shown to exist in a respiratory syncytial virus [177]. These 
viruses are a very common source of respiratory tract infection, and nearly all children have been 
infected with this class of virus by the age of 3. 
Many bacteria, including E. coli [178,179], produce the enzyme taurine α-ketoglutarate 
dioxygenase under conditions of sulfate starvation, which catalyzes the hydroxylation of taurine, in the 
presence of oxygen and α-ketoglutarate (αKG), to yield carbon dioxide, succinate, sulfite, and 
aminoacetaldehyde [180]. Since sulfite readily oxidizes to sulfate via sulfite oxidase, allowing bacteria 
to carry out this reaction would be very effective in renewing sulfate supplies. The observed release of 
glutamate, αKG and succinate from astrocytes under stressful conditions [181] would supply bacteria 
infiltrating the brain with raw materials to carry out this reaction, thus supplying sulfate to the brain. 
An interesting corollary to this idea is that the reaction could potentially build up an excess of 
carbon dioxide in the brain, which might explain the abnormalities in serotonin response observed in 
association with ASD [182,183]. In [184], a unified theory for the serotonin system is proposed, which 
argues that the sensing of excess CO2 by the serotonergic neurons in the brain stem nuclei leads to 
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diverse responses besides controlling breathing, which could explain the anxiety and sleep disorders 
(arousal from sleep) associated with ASD, all tied to a common goal of maintaining serum pH 
homeostasis in the presence of an excess of CO2. 
Another way in which bacteria may contribute is through the remarkable ability of some bacterial 
DNA to produce electromagnetic fields, which could conceivably play a role in seizure initiation. In 
recent work by Montagnier et al. [185] electromagnetic signals (EMS) were detected from various 
cell-free bacterial DNA sequences, at high dilutions, thought to possibly originate from aqueous 
nanostructures. This suggests to us that highly structured, quantum coherent water, e.g., that found in 
an ensemble of water CDs, is involved in the formation of these nanostructures. A Grotthuss-style 
proton-hopping mechanism could be envisioned to provide the charge separation and current [114], 
while the energy for the EMS emission might be provided by sunlight and noise energy captured from 
the environment by the water CDs. 
10. The Reaction Cascade 
This section describes the complete signaling cascade that characterizes the encephalitic response, 
schematized in Figure 1. It seems that a sufficient precondition is severe depletion of free sulfate in the 
blood as well as sulfate in the GAGs in the glycocalyx and the extracellular matrix proteins of 
suspended red blood cells and platelets. Excess ammonia induced by environmental toxins will result 
in an enhanced production of nitric oxide by inducible NOS (iNOS) in activated macrophages, 
triggering the cascade. An aluminum-containing vaccine has the potential to initiate an acute response 
in the child who is predisposed due to widespread sulfate deficiencies. Aluminum’s strong  
calmodulin-binding tendencies induce eNOS in the artery wall to synthesize excess NO [186], beyond 
the immune response induced by the antigen in the vaccine. A child who is already over-producing 
nitric oxide, for example in response to endotoxins being released by gram-negative bacteria in a leaky 
gut environment, would be especially vulnerable. The end result is a profusion of NO released into the 
blood stream, which results in the excess production of ammonia, mediated by GSH. GSH reacts with 
NO to produce GSNO, which is metabolized to release ammonia as already described above. The 
result is an additional burden beyond what is already being produced by microbes in the impaired gut, 
for example due to excess glyphosate exposure. 
The ammonia and the NO provoke, after Selye-type sensitization [187], a cascade in the brain 
which begins with the opening up of the blood-brain barrier, allowing entry of water, glutamate, 
neutrophils, and bacteria. A concurrent increased permeability of the gut barrier allows microbes from 
the gut to gain entry into the blood, and hence into the brain. Neutrophils, also entering through the 
leaky barrier, will launch an attack, releasing cytokines and reactive oxygen and nitrogen species such 
as H2O2, NO, O2
−, ONOO− and HOCl. Bacteria like Chlamydia pneumoniae and viruses like 
respiratory syncytial virus, that can produce heparan sulfate in vacuoles, may flourish inside the 
immune cells long enough to yield an abundant product, as a direct consequence of impaired 
lysosomal function, thus inadvertently assisting in the recovery process. 
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Figure 1. Schematic of cascade that we believe leads to ASD, which can best be 
characterized as low-grade chronic encephalitis, brought on by impaired sulfate synthesis. 
The activities in the brain are corrective in that they produce sulfate to resupply the blood 
and the tissues, leading to healing. However, the damaging effects of chronic ammonia and 
glutamate exposure lead over time to brain impairment, which is especially apparent in the 
hippocampus. The four boxes indicating dysfunction (in yellow) identify phenomena that 
are closely associated with or directly give rise to ASD/encephalitis symptoms. HS: 
heparan sulfate; NMDA: N-methyl-D-aspartate.  
 
Astrocytes react to the presence of excess ammonia and water initially by swelling, followed by the 
release of several osmolytes [188], but most important are glutamate and taurine. Glutamate plays an 
important role in supplying an alternative fuel to the neurons, allowing them to bypass mitochondrial 
stage I, thus reducing the need for release of superoxide in complex I, which could react with NO to 
produce the toxic agent, peroxynitrite. Glutamate is also a precursor for α-ketoglutarate (αKG), which 
can supply bacteria the necessary metabolite to support sulfate synthesis from taurine [178–181].  
The taurine released by astrocytes plays two very important roles. The first is to neutralize the 
HOCl that escapes from the phagolysosomes of the neutrophils before it can do damage to the cell 
membranes of neighboring cells [96]. Such damage would lead to excess ion leaks and impaired 
membrane transport, ultimately resulting in cell lysis [76]. The second role is to replenish depleted 
sulfate, both in the blood stream and in the brain. Conversion to taurine chloramine is an important 
first step in activating taurine so that it can be fully metabolized [97]. However, taurine can also be 
metabolized directly to sulfate by any bacteria that remain viable [98,99]. The mental confusion or 
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even coma associated with acute encephalitis may result from excess CO2 exposure in the brain stem 
nuclei due to taurine metabolism, and reflects the need to minimize the metabolic requirements of the 
neurons during a time when glucose supply is short, due to the suppression of glucose transport 
mechanisms by excess HOCl. Minimizing the activities in Complex I helps prevent damage to the 
iron-sulfur clusters there by peroxynitrite [68]. 
ASD is associated with deficiencies in magnesium [100], zinc [118], and various sulfur  
metabolites [38]. A dangerous condition can arise when these nutrients are severely depleted, as it has been 
established that both magnesium and heparan sulfate play important roles in xenophagy, the processes in 
the phagolysosome leading to capture, killing and digestion of the invasive microbes [106]. As previously 
shown the zinc ion in eNOS may play a catalytic role in the synthesis of sulfate from eNOS [23].  
Impairments in phagocytosis would likely lead to the accumulation of debris from dead bacteria in 
the blood stream. Thus, the possibility of developing specific antibodies to the proteins and DNA in 
the debris and mimicry could lead to autoimmune reactions to similar native proteins and DNA [189]. 
Such a basis has been proposed as a possible cause of multiple sclerosis [190], involving an 
autoimmune attack on myelin as a consequence of exposure to otherwise harmless gut bacteria in the 
brain. In [191], it was shown that ASD is associated with an increased risk of autoantibody response to 
a specific but unidentified protein of molecular weight 52 kDa found in cells in the cerebellum. Thus, a 
similar situation might explain some of the neuronal damage in ASD. 
Mono-anionic sulfates, i.e. the sulfated GAGs and sterol sulfates, are essential in stabilizing cell 
membranes of suspended cells. They support the EZs necessary to keep red blood cells and platelets 
dispersed, thereby preventing them from aggregating, agglutinating, and coagulating, and they promote 
barrier function [16]. Furthermore, cholesterol sulfate synthesis is essential to replenish cholesterol 
supply, as well as sulfate supply, to cell membranes. The seizures and fever, we propose, are necessary 
to support the synthesis of sulfate by eNOS and nNOS in red blood cells, platelets, endothelial cells, 
and neurons. Recent advances in our understanding of the special properties of interfacial water show 
how seizures may supply electric currents that would enable water to form nanomolecular clusters 
of quantum coherent water: coherence domains (CDs). These would enhance proton transport, 
Grotthuss-style “proton-hopping”, to support the reactions, localized to caveolae, that oxidize sulfur 
to sulfate and combine it with cholesterol to produce cholesterol sulfate, presumably although not 
necessarily involving eNOS and nNOS. A non-enzymatic process has not been excluded. On-water 
heterogeneous catalysis is likely involved in both enzymatic and non-enzymatic mechanisms. 
Absence epilepsy is a relatively common condition that appears in young children, characterized by 
frequent short intervals of loss of consciousness in association with seizures. Glutamatergic receptors 
are involved in maintaining a state of consciousness [192]. In a mouse model of absence epilepsy, it 
has been demonstrated that the condition is associated with impaired metabolism in the cerebellum and 
cortex, reflected in increased rates of glycolysis (cytoplasmic metabolism of glucose to pyruvate) and 
increased use of glutamate as an energy source in the mitochondria [193]. This is easily explained as a 
mechanism to spare complex I of the mitochondrial electron transport chain. The excess bioavailability 
of glutamate in the synapse leads to increased glutamatergic activity in the thalamus, resulting in a 
suppression of thalamic input to the cortex and impaired conscious awareness. Interestingly, the mice 
with genetically-induced absence epilepsy exhibited improved memory, suggesting that the reaction 
cascade associated with seizures may have benefitted their memory system. 
Entropy 2013, 15 391 
 
 
11. Discussion 
This paper shows how a finely choreographed biosemiotic cascade associated with encephalitis may 
help restore depleted sulfate supplies to the brain and blood stream. Because ASD involves a severe 
deficiency in sulfate, it follows that ASD can be characterized as low-grade encephalitis, with 
compromised immune system involvement [194]. Inflammation in the brain is a characteristic feature 
of ASD [195], and recent reviews have discussed the role of “neuroimmune interactions” [172,173] 
Such features in ASD, and in various other disorders and disease conditions, are explained by the 
proposed inflammation cascade. Zinc and magnesium deficiency are associated with reduced levels of 
serum sulfate in patients with many chronic diseases, including myalgic encephalomyelitis, irritable 
bowel syndrome, migraine, arthritis, multiple chemical sensitivity and depression [196]. Furthermore, 
extremely low blood serum ratios of sulfate to cysteine are found in association with Alzheimer's disease, 
Parkinson's disease and amyotrophic lateral sclerosis (ALS) [197]. Sulfate deficiency is also associated 
with all these other neurological conditions suggesting wide relevance of the proposed signaling 
cascade beyond its application to ASD. 
A recent study using metabolomics to detect abnormal amounts of a large number of metabolites in 
urinary specimens from subjects with ASD compared to controls has revealed a number of significant 
differences [198], many of which are in alignment with the signaling cascade presented here. First of 
all, researchers found that subjects with both ASD and digestive disturbances indicative of 
inflammatory bowel disease had increased levels of bacterial co-metabolites in their urine, suggesting 
bacterial invasion and impaired endocytosis. Secondly, they observed a very low level of taurine in 
urine specimens from subjects with ASD, indicative of taurine depletion. Thirdly, they observed a 
marked increase in the concentration of urinary gamma glutamyl transferase, an enzyme which can 
supply glutamate by breaking down glutathione. This would predict both excess glutamate and 
depleted glutathione, both of which are found in association with ASD. Finally, products indicative of 
oxidative stress were more highly concentrated in the urine of subjects with ASD.  
Insufficient sulfate supply to the blood has potentially catastrophic consequences. To explain this 
requires consideration of the anomalous properties of water, especially the ability of water to create 
EZs surrounding negatively charged hydrophilic regions, i.e., polyanionic biomembranes. When there 
is insufficient sulfate in the extracellular matrix proteins, i.e., the heparan sulfate glycosaminoglycans, 
of cells suspended in the blood, these cells are predisposed to aggregate and agglutinate, resulting in a 
coagulation cascade that could lead to thrombosis and death if left unchecked. Impaired cholesterol 
sulfate delivery to the fetus during pregnancy followed by impaired cholesterol sulfate synthesis in the 
skin postnatally leads to a global deficiency in sulfate supply to the extracellular matrix proteins in 
association with ASD [21]. X-linked ichthyosis, a genetic disease affecting the enzyme steroid 
sulfatase, and thus impairing the ability to break down cholesterol sulfate into cholesterol and 
sulfate, is associated with increased risk to both ADHD and ASD and with an accumulation of 
cholesterol sulfate in the outer epidermis [199]. 
Deficiencies in magnesium, zinc, glutathione, sulfate, and, particularly, heparan sulfate are 
associated with pathologies related to ASD. Displacement in the diet of animal protein, fat, and 
cholesterol by grains, whose components can actively bind and flush out or leak minerals and other 
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compounds from the gut, may contribute to the deficits. Food-based toxic chemicals such as 
glyphosate, the most widely used herbicide in agricultural practices, are also implicated.  
Impairment in heparan N-sulfatase can lead to ASD-like behaviors in humans, as exemplified by 
the lysosomal storage disease, Sanfilippo syndrome [55]. Thus, lysosomal dysfunction is likely a factor 
in ASD. However, heparan sulfate also plays an important role in neural transmission. The authors of 
the paper that showed ASD-like behaviors in mice with impaired heparan sulfate supply stated that 
“removal of HS (heparan sulfate) compromises glutamatergic synaptic transmission by affecting the 
synaptic localization of AMPA receptors” ([52], pp. 5052–5053). Thus, there is a direct link between 
heparan sulfate deficiencies, glutamate, and neuronal dysfunction. The syndecans in heparan sulfate 
proteoglycans play a supporting role in cell migration, neurite extension, and plasticity, important 
aspects of neural development [200]. Heparan sulfate is enriched in synapses, and it is involved in the 
morphological maturation of dendritic spines in rat hippocampal neurons [201]. It is also involved in 
long-term potentiation in the hippocampus [202], which has been shown to be impaired in ASD [94]. 
Neural synaptic transmission defects in the hippocampus are implicated in the pathology of ASD. 
By comparing the patterns of cognitive dysfunction in ASD and adult amnesia with the deficits 
associated with hippocampal lesions in animals, DeLong has made a case for hippocampal dysfunction 
as a main contributor to the cognitive and motivational deficits observed in ASD [203]. Epilepsy is a 
strong feature associated with ASD [204,205], and it has been demonstrated that epilepsy is associated 
with reduced complex I activity in the hippocampus [206]. This fits well with the model that glutamate 
is entering the citric acid cycle beyond mitochondrial complex I. 
The flooding of the extracellular fluid with glutamate could be a key contributor to the observed impaired 
glutamatergic signaling in ASD. Serum glutamate levels are abnormally high in ASD [207]. In the 
hippocampus, a large percentage of the glutamate receptors are located outside of the synapse. This 
extrasynaptic pool triggers a signaling cascade that inactivates NMDA receptors in the synapse [208]. 
Mutations in NMDA glutamate receptors have been found to be causative in certain rare cases of  
ASD [209]. The presence of large amounts of glutamate outside the cell in non-synaptic regions is a 
signal of metabolic stress, thus resulting in the shutting down of receptors in the synapse in order to 
conserve energy. However, the net result is impaired glutamatergic signaling. 
While the signaling cascade proposed in this paper involves plausible inferences at many points, it 
provides evidence that conditions that appear at first to be pathological, such as encephalopathies, may 
be part of a larger and more coherent biosemiotic process that is protective and salubrious. To the 
extent that the ideas suggested are on the right track, they provide hope for a child diagnosed with 
ASD. Biological cascades evidently exist in part to maintain a supply of taurine and glutamate to 
protect neurons from collateral damage during a necessary and productive inflammatory response. 
Such systems may protect neurons against permanent damage. The neurons are being maintained in a 
chronic state of suppressed glutamatergic signaling, due to sustained exposure to excess NO and 
derivative oxidative and nitrosative products.  
There is evidence in the research literature that dietary supplements related to the deficiencies 
discussed here can improve symptoms and/or biomarkers in ASD. Parents of children with ASD have 
found empirically that a gluten-free diet helps improve the behavior of their children, and  
placebo-controlled studies have shown modest benefits [210]. Since gluten contains phytates, which 
deplete minerals such as zinc and magnesium, this could be a factor in the observed improvements. 
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Evidence for a role for thiamine deficiency comes from a study where eight out of 10 children with ASD 
improved clinically following thiamine tetrahydrofurfuryl disulfide treatment [211]. A placebo-
controlled study involving 141 children with ASD demonstrated improvements in several sulfur-
related biomarkers, including total sulfate, adenosylmethionine, GSH, GSSG:GSH ratio, and taurine, 
following a vitamin/mineral supplement treatment program that specifically included methylsulfonyl-
methane (MSM) as a sulfur source [212], supporting the concept of sulfur deficiency in association 
with ASD. Cholesterol supplementation has been shown to improve symptoms such as irritability, 
hyperactivity, and sleep disorders in some children with ASD [213]. This is particularly true for those 
diagnosed with Smith-Lemli-Opitz syndrome (SLOS), a condition caused by genetic mutations in a 
gene involved in cholesterol synthesis associated with the ASD phenotype [214,215]. 
The analysis presented here suggests certain simple adjustments in lifestyle and nutrition to 
reduce the risk of ASD in a child, or to improve the prognosis. The first step is to make sure that 
the diet is adequate in supplying zinc, magnesium, thiamine and sulfur, for both the pregnant 
mother and the child. A conscious effort to consume organic non-genetically modified vegetables is 
encouraged, along with a reduction in dietary sugars and processed carbohydrates. Since taurine is 
absent from plant-based foods, it is important to include sufficient animal proteins in the diet, for 
adequate supply of taurine. Grains should be avoided, as phytates bind minerals such as magnesium 
and zinc and prevent their uptake through the gut, a concept that has been popularized by the 
cardiologist William Davis [216]. Epsom salt baths may be of therapeutic benefit, as they could 
provide magnesium sulfate, which is readily absorbed through the skin [196]. 
Another key lifestyle change is to assure adequate sun exposure to the skin. A recent study has 
confirmed a strong inverse correlation between ASD prevalence in the individual states within the 
United States and the calculated mean annual solar UVB availability, suggesting that ASD risk is 
increased by inadequate UVB exposure [217]. This is further supported by evidence that inflammatory 
bowel disease incidence is higher in geographical regions with less sunlight availability [218]. High 
SPF sunscreens often contain aluminum hydroxide as an emulsifier, which could provide synergistic 
effects, along with the aluminum burden from vaccines [219]. 
12. Conclusions 
Encephalitis can be viewed as a response of the body to the need to augment the supply of sulfate to 
the brain and to the blood stream, under conditions of extreme deficits. Autism spectrum disorder can 
be framed as a condition associated with chronic low-grade encephalitis, which maintains the brain in 
a hypometabolic state in order to protect it from oxidation and nitration damage. The pathology arises 
from impaired cholesterol sulfate synthesis in the skin, due to insufficient sunlight exposure and 
excessive use of sunscreens. Exposure to toxic metals such as aluminum, mercury and lead, and to 
toxic chemicals such as those found in commonly used herbicides, further deplete the supply of sulfate 
and other micronutrients to the blood stream and the tissues, potentially leading to a life-threatening 
state of blood instability. The reaction cascade associated with encephalitis, involving fever, seizures, 
neutrophil activation, and the release of glutamate and taurine from astrocytes, can be protective and 
salubrious in partially regenerating sulfate supplies to stabilize the blood and improve neuronal 
synaptic transmission. While the proposed biosemiotic cascade involves inferences, they are plausible 
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and well supported by existing research and theory, and the entire proposal can help to guide further 
research. The upside is to encourage research seeking to prevent ASD and many other disorders and 
disease conditions. Proposed remedies involve simple changes such as abundant sun exposure, 
avoidance of environmental toxins and chelating agents, avoidance of dietary processed foods, grains 
and sugars, and greater intake of sulfur-containing foods. 
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